Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BioSpektrum is Scopus-indexed (Q4, CiteScore 0.1). It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Spektrum.
Checked against the index lists dated .
ISSN 0947-0867Verify ISSN ↗1868-6249Verify ISSN ↗
Publisher: Springer Spektrum
Cost to publish: About US$3,190 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 321 / 325 | 1st | Q4 |
| Molecular Biology | 414 / 414 | 0th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q4, CiteScore 0.1.
BioSpektrum is Q4 in Biotechnology (rank 321 of 325) and Q4 in Molecular Biology (rank 414 of 414), by CiteScore 2025.
BioSpektrum is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 1st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.106, quartile Q4, with an H-index of 6.
The publisher lists an article processing charge of about US$3,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
BioSpektrum is published by Springer Spektrum. Its print ISSN is 0947-0867 and its online ISSN is 1868-6249.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
BioSpektrum has an h-index of 7 and a 2-year mean of 0.05 citations per paper (OpenAlex). Its Scopus CiteScore is 0.1, quartile Q4. On 2-year citations it ranks #286 of 309 Scopus journals in Biotechnology.
BioSpektrum published 243 papers in 2025; its busiest recent year was 2024 with 263. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 70 research articles (2026), authors are most often from Germany (86.4%), Switzerland (3.6%) and Austria (2.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.